Why US MoCRA Compliance Matters for Imported Cosmetics
The Modernization of Cosmetics Regulation Act, commonly known as MoCRA, represents the most significant overhaul of US cosmetic regulations in decades. For brand owners and B2B buyers sourcing products from China, understanding this legislation is no longer optional—it is a critical requirement for market access. The United States FDA now enforces stricter standards regarding facility registration, product listing, adverse event reporting, and safety substantiation. Importers must ensure their manufacturers are fully compliant to avoid shipments being detained at customs or facing regulatory action.
Many international brands previously operated under a framework that lacked mandatory federal oversight for cosmetic facilities. MoCRA closes these gaps by imposing obligations on both domestic and foreign manufacturers. As a result, partners who can demonstrate clear compliance with US MoCRA compliance checklist requirements gain a competitive advantage. They offer brands greater supply chain security, reduced regulatory risk, and faster time-to-market for new product launches in the United States.
How to Verify a Factory Against US MoCRA Compliance Checklist Standards
Before selecting a manufacturing partner, it is essential to validate their regulatory readiness. A reliable OEM or ODM provider should maintain transparent documentation and hold recognized quality certifications. Our facility operates under ISO 22716 and GMPC standards, which align closely with Good Manufacturing Practice requirements expected by global regulators. Additionally, we maintain FDA registration as a cosmetic facility, a foundational step for any manufacturer exporting cosmetics to the United States.
When evaluating a potential supplier, ask for proof of their current facility registration number and product listing status. A complete US MoCRA compliance checklist includes verification that the factory is registered with the FDA and that its cosmetic products are listed in the FDA’s database. Brands should also request documentation showing that the manufacturer has established procedures for adverse event reporting and serious adverse event records, as these are mandatory under the new law.
Facility Registration and Product Listing: What You Must Confirm
Under MoCRA, every cosmetic facility that manufactures or processes products for sale in the US must register with the FDA. This includes foreign facilities, such as those located in China, and the requirement applies regardless of whether the products are private label or custom developed. Product listing further requires disclosure of each cosmetic product’s ingredients and other relevant information. Buyers should confirm that their contract manufacturer handles these registrations proactively rather than leaving them as an afterthought.
We operate a 10,000 m² factory in Guangzhou, equipped with 35+ R&D scientists who support custom formula development and regulatory alignment. Our team has developed 10,000+ formulas and holds 50+ patents, reflecting our commitment to innovation within a compliant framework. By partnering with a facility that already manages registration and listing processes, brands can streamline their entry into the US market and reduce administrative burdens.
Safety Substantiation and Ingredient Compliance
MoCRA mandates that cosmetic products be adequately substantiated for safety before they reach consumers. While the FDA does not require premarket approval for most cosmetics, manufacturers must have evidence that their products are safe for use under labeled or customary conditions. This includes reviewing ingredient safety, considering potential contaminants, and evaluating packaging interactions.
Our expertise covers a wide range of categories, including Face Care, Eye Care, Men's Care, Baby Skincare, Body Care, Hair Care, Lip Care, and Hand Care. Each product line requires careful attention to ingredient selection and formulation stability. The FDA also maintains lists of prohibited and restricted ingredients, and compliant manufacturers stay updated on these changes. With over 20 years of experience, our R&D team ensures that formulations meet both performance expectations and regulatory safety standards.
- Conduct thorough ingredient reviews against FDA prohibitions and restrictions
- Maintain safety substantiation dossiers for all finished products
- Monitor regulatory updates and adjust formulations as needed
Adverse Event Reporting and Recordkeeping Requirements
One of the newer and most impactful provisions of MoCRA is the requirement for adverse event reporting. Manufacturers must maintain records of any serious adverse events associated with their cosmetic products and report certain incidents to the FDA. This system helps regulators monitor product safety in real time and takes a proactive approach to consumer protection.
Brands sourcing from China should confirm that their factory has established internal procedures for collecting, investigating, and recording adverse event information. A mature quality management system, such as the one supported by our ISO 22716 and GMPC certifications, provides the structure needed to comply with these reporting obligations. Exporting to 60+ countries has further refined our ability to manage complex regulatory requirements and maintain rigorous documentation standards.
Labeling, Packaging, and Ongoing Compliance
Labeling is another area where MoCRA introduces significant changes. Cosmetics sold in the US must now include a functional claim statement, a business name and place of business, and accurate net content disclosure. Additionally, manufacturers must provide a unique identifier for certain products to enable tracking. Packaging and labeling compliance must be addressed early in the product development process to avoid costly delays.
Our OEM and ODM services support custom formula development from concept to finished product. Whether you are launching a new skincare line or scaling an existing brand, working with a manufacturer who understands US labeling rules can prevent compliance gaps. We assist clients in navigating these requirements as part of a comprehensive US MoCRA compliance checklist review, ensuring that every batch meets current regulatory standards.
With decades of industry experience and a large-scale production facility, Guangzhou Laiyue Biological Group Co., Ltd. is positioned to support international brands seeking reliable, compliant cosmetic manufacturing. Our dedicated team works closely with partners to align formulations, documentation, and labeling with US regulatory expectations.
If you are preparing to launch or expand your cosmetic brand in the United States, we encourage you to reach out for a consultation. WhatsApp +86 18709713948 · Email adon@oemcosmeticsodm.com · Website www.oemcosmeticsodm.com